New Hampshire House Bill 1702 introduces severe regulations for abortion medication that could lead to felony charges for noncompliance by pharmacists and medical providers. This bill is seen as a criminalization of routine healthcare rather than a regulatory improvement, creating fear and deterring professionals from providing necessary services, thus limiting access to care.
New Hampshire House Bill 360 aims to ban public schools from performing surgeries or prescribing pharmaceuticals, targeting a practice that does not exist. It diverts attention from pressing issues like housing and healthcare, reflecting distorted legislative priorities influenced by culture-war politics. Ultimately, it signals a troubling disconnect with reality and public concerns.
The FAA currently prohibits pilots from using ADHD medications, despite evidence showing they enhance attention and performance. This outdated rule discourages pilots from seeking treatment, compromising safety. With a pilot shortage, the FAA should adopt an evidence-based approach, allowing regulated medication use to improve both safety and transparency in aviation.
In New Hampshire, abortion is legal, but as of 2022, it’s a right with a clear time limit. The state’s primary regulation, a law called the Fetal Life Protection Act, prohibits abortions at 24 weeks of gestation or later. This statute is formally known as RSA 329:43-50. This ban isn’t…
Public health policy is a strategic framework of laws and actions designed to prevent disease and promote community health, emphasizing prevention, equity, and population-wide impact. By focusing on these principles, policies have historically driven significant improvements in public health outcomes, demonstrating the crucial role of proactive measures in enhancing community well-being.
New Hampshire faces severe consequences from federal Medicaid cuts under the OBBBA, potentially leading to over one preventable death per week and increased medical debt. To mitigate this, the state must act by filling funding gaps, reforming Medicaid administration, strengthening subsidies, enhancing preventive care, and raising public awareness to protect vulnerable populations.
New Hampshire’s overdose deaths declined significantly in 2024, part of a national trend, yet fentanyl remains prevalent in the drug supply. Despite progress, the state’s drug landscape is complex, with heightened risks from polydrug use involving stimulants and xylazine. Ongoing harm-reduction efforts and treatment advancements are crucial to maintain gains.